Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone in Treatment of Cocaine Dependence
NCT00015080Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- May 1995
- Primary completion
- Jun 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine dependence comparing Naltrexone with Placebo (2 arms). Primary endpoints: Retention in treatment, Cocaine use by self-report and 7 more. Started May 1995; status: completed.
02
Drugs
naltrexone
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00015080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015080.